WEBSITE BSE:544432 NSE: IGCL Inc. Year: 1993 Industry: Pesticides & Agrochemicals My Bucket: Add Stock
Last updated: 15:52
No Notes Added Yet
Indogulf Cropsciences Ltd. is an Indian agrochemical company, founded in 1993, that manufactures and sells crop‑protection products (insecticides, herbicides, fungicides, plant‑growth regulators), plant nutrients, and biologicals. The company operates multiple manufacturing plants across India and serves both retail and institutional clients with a wide portfolio of formulations — granules, liquids, concentrates and more. It combines its own technical‑grade synthesis capabilities (for agro‑chemical “technical” ingredients) with fo...Read More
Indogulf Cropsciences Ltd. is an Indian agrochemical company, founded in 1993, that manufactures and sells crop‑protection products (insecticides, herbicides, fungicides, plant‑growth regulators), plant nutrients, and biologicals. The company operates multiple manufacturing plants across India and serves both retail and institutional clients with a wide portfolio of formulations — granules, liquids, concentrates and more. It combines its own technical‑grade synthesis capabilities (for agro‑chemical “technical” ingredients) with formulation and export infrastructure, and exports its products to over 30 countries, earning recognition as an export house. In recent years it has expanded its product offering — growing from under 200 products to nearly 290 — while building a large domestic distribution network across many Indian states. In 2025 the company raised fresh capital through an IPO to support working‑capital needs, set up a new manufacturing line (dry flowable plant), repay debt, and fuel growth. Indogulf is positioned as a mid‑size but diversified agrochemicals player with in‑house R&D and backward‑integration — though its business remains exposed to agro‑sector cycles, regulatory environment, raw‑material costs and seasonality. ...Read Less
Our experts help you choose the right stocks based on performance, risk, and growth potential.
Market Cap ₹404 Cr.
Stock P/E 12.8
P/B 0.9
Current Price ₹64
Book Value ₹ 70.2
Face Value 10
52W High ₹121.9
Dividend Yield 0%
52W Low ₹ 49.6
Price goes above X
Price falls below X
PE goes above X
PE falls below X
₹ | |
| #(Fig in Cr.) | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 |
|---|---|---|---|---|---|---|---|---|
| Net Sales | 139 | 132 | 233 | 99 | 126 | 189 | 248 | 116 |
| Other Income | 2 | 0 | 1 | 1 | 2 | 1 | 2 | 3 |
| Total Income | 141 | 133 | 234 | 100 | 128 | 190 | 250 | 119 |
| Total Expenditure | 119 | 126 | 205 | 89 | 105 | 179 | 216 | 104 |
| Operating Profit | 22 | 6 | 28 | 11 | 23 | 11 | 34 | 14 |
| Interest | 3 | 3 | 3 | 4 | 4 | 4 | 5 | 4 |
| Depreciation | 3 | 2 | 3 | 2 | 3 | 2 | 3 | 3 |
| Exceptional Income / Expenses | 1 | 1 | 0 | -0 | 0 | 0 | 0 | 0 |
| Profit Before Tax | 18 | 2 | 23 | 5 | 15 | 5 | 27 | 7 |
| Provision for Tax | 5 | 1 | 6 | 1 | 5 | 1 | 6 | 4 |
| Profit After Tax | 13 | 1 | 17 | 4 | 10 | 4 | 21 | 4 |
| Adjustments | 0 | 0 | 0 | 0 | 0 | 0 | 0 | -0 |
| Profit After Adjustments | 13 | 1 | 17 | 4 | 10 | 4 | 21 | 4 |
| Adjusted Earnings Per Share | 2.8 | 0.3 | 3.4 | 0.8 | 2 | 0.8 | 3.3 | 0.6 |
| #(Fig in Cr.) | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | TTM |
|---|---|---|---|---|---|
| Net Sales | 487 | 550 | 552 | 590 | 679 |
| Other Income | 4 | 3 | 5 | 4 | 8 |
| Total Income | 491 | 552 | 557 | 595 | 687 |
| Total Expenditure | 441 | 501 | 494 | 526 | 604 |
| Operating Profit | 50 | 51 | 63 | 68 | 82 |
| Interest | 6 | 12 | 13 | 15 | 17 |
| Depreciation | 9 | 10 | 10 | 11 | 11 |
| Exceptional Income / Expenses | 0 | 0 | -4 | 1 | 0 |
| Profit Before Tax | 36 | 30 | 36 | 45 | 54 |
| Provision for Tax | 9 | 8 | 8 | 13 | 16 |
| Profit After Tax | 26 | 22 | 28 | 31 | 39 |
| Adjustments | 0 | 0 | 0 | 0 | 0 |
| Profit After Adjustments | 26 | 22 | 28 | 31 | 39 |
| Adjusted Earnings Per Share | 5.6 | 4.8 | 6 | 6.5 | 6.7 |
| # | 1 Year | 3 Year | 5 Year | 10 Year |
|---|---|---|---|---|
| Sales CAGR | 7% | 7% | 0% | 0% |
| Operating Profit CAGR | 8% | 11% | 0% | 0% |
| PAT CAGR | 11% | 6% | 0% | 0% |
| # | 1 Year | 3 Year | 5 Year | 10 Year |
|---|---|---|---|---|
| Share Price CAGR | NA% | NA% | NA% | NA% |
| ROE Average | 12% | 12% | 13% | 13% |
| ROCE Average | 13% | 13% | 13% | 13% |
| #(Fig in Cr.) | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 |
|---|---|---|---|---|
| Shareholder's Funds | 181 | 203 | 232 | 275 |
| Minority's Interest | 0 | 0 | 0 | 0 |
| Borrowings | 14 | 22 | 19 | 36 |
| Other Non-Current Liabilities | 11 | 12 | 11 | 13 |
| Total Current Liabilities | 208 | 281 | 281 | 364 |
| Total Liabilities | 414 | 518 | 542 | 688 |
| Fixed Assets | 57 | 69 | 48 | 47 |
| Other Non-Current Assets | 33 | 27 | 42 | 81 |
| Total Current Assets | 323 | 421 | 452 | 559 |
| Total Assets | 414 | 518 | 542 | 688 |
| #(Fig in Cr.) | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 |
|---|---|---|---|---|
| Opening Cash & Cash Equivalents | 6 | 5 | 4 | 3 |
| Cash Flow from Operating Activities | -7 | -57 | 53 | -15 |
| Cash Flow from Investing Activities | -10 | -19 | -5 | -40 |
| Cash Flow from Financing Activities | 16 | 75 | -49 | 61 |
| Net Cash Inflow / Outflow | -1 | -1 | -1 | 7 |
| Closing Cash & Cash Equivalent | 5 | 4 | 3 | 10 |
| # | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 |
|---|---|---|---|---|
| Earnings Per Share (Rs) | 5.6 | 4.77 | 6 | 6.45 |
| CEPS(Rs) | 7.43 | 6.81 | 8.19 | 8.62 |
| DPS(Rs) | 0 | 0 | 0 | 0 |
| Book NAV/Share(Rs) | 38.35 | 43.18 | 49.22 | 56.42 |
| Core EBITDA Margin(%) | 9.17 | 8.59 | 10.18 | 10.34 |
| EBIT Margin(%) | 8.21 | 7.37 | 8.54 | 9.52 |
| Pre Tax Margin(%) | 7.02 | 5.33 | 6.29 | 7.18 |
| PAT Margin (%) | 5.19 | 3.94 | 4.92 | 5.07 |
| Cash Profit Margin (%) | 6.89 | 5.63 | 6.72 | 6.78 |
| ROA(%) | 6.37 | 4.82 | 5.33 | 5.12 |
| ROE(%) | 14.61 | 11.69 | 12.99 | 12.42 |
| ROCE(%) | 14.78 | 12.44 | 12.58 | 13.4 |
| Receivable days | 101.84 | 102.01 | 126.61 | 130.6 |
| Inventory Days | 109.17 | 115.75 | 128.67 | 136.73 |
| Payable days | 111.02 | 87.89 | 95.53 | 117.33 |
| PER(x) | 0 | 0 | 0 | 0 |
| Price/Book(x) | 0 | 0 | 0 | 0 |
| Dividend Yield(%) | 0 | 0 | 0 | 0 |
| EV/Net Sales(x) | 0.25 | 0.38 | 0.32 | 0.44 |
| EV/Core EBITDA(x) | 2.4 | 4.07 | 2.78 | 3.8 |
| Net Sales Growth(%) | 0 | 12.82 | 0.47 | 6.92 |
| EBIT Growth(%) | 0 | 0.71 | 16.76 | 20.62 |
| PAT Growth(%) | 0 | -14.95 | 25.91 | 11.47 |
| EPS Growth(%) | 0 | -14.95 | 25.91 | 7.48 |
| Debt/Equity(x) | 0.56 | 0.93 | 0.67 | 0.8 |
| Current Ratio(x) | 1.55 | 1.5 | 1.61 | 1.53 |
| Quick Ratio(x) | 0.82 | 0.75 | 0.91 | 0.79 |
| Interest Cover(x) | 6.91 | 3.6 | 3.78 | 4.07 |
| Total Debt/Mcap(x) | 0 | 0 | 0 | 0 |
| # | Jun 2025 | Jul 2025 | Sep 2025 | Dec 2025 | Mar 2026 |
|---|---|---|---|---|---|
| Promoter | 96.87 | 96.87 | 69.05 | 69.05 | 69.05 |
| FII | 0 | 0 | 0.41 | 0.21 | 0.24 |
| DII | 0 | 0 | 5.87 | 4.11 | 4.36 |
| Public | 3.13 | 3.13 | 24.67 | 26.63 | 26.35 |
| Others | 0 | 0 | 0 | 0 | 0 |
| Total | 100 | 100 | 100 | 100 | 100 |
| # | Jun 2025 | Jul 2025 | Sep 2025 | Dec 2025 | Mar 2026 |
|---|---|---|---|---|---|
| Promoter | 4.73 | 4.73 | 4.37 | 4.37 | 4.37 |
| FII | 0 | 0 | 0.03 | 0.01 | 0.02 |
| DII | 0 | 0 | 0.37 | 0.26 | 0.28 |
| Public | 0.15 | 0.15 | 1.56 | 1.68 | 1.67 |
| Others | 0 | 0 | 0 | 0 | 0 |
| Total | 4.88 | 4.88 | 6.32 | 6.32 | 6.32 |
* The pros and cons are machine generated.
You May Also Know About
Looking to buy unlisted shares or need guidance on the investment process? Our expert Private Equity Advisors are here to assist you with accurate information, real-time pricing, and seamless execution.
Want to sell unlisted shares, liquidate your ESOPs, or understand the step-by-step process of liquidation? Connect with our Buying Team for smooth coordination, quick evaluations, and end-to-end support.
Planning to build or grow your portfolio? For Mutual Fund investments, PMS solutions, tailored portfolio creation, and overall wealth management, our dedicated Wealth Team is ready to guide you.
ChatGPT
Claude
Perplexity
